Trump's tariffs could hit the Hungarian pharmaceutical company too
Drugs maker expects significant growth, especially in the women's healthcare and biotech segments
Portfolio expanding
Interview with Gábor Orbán
FDA accepts license application for review
Márton Nagy says the pharmaceutical sector could be one of the drivers of economic recovery
Third-quarter flash report came in
Analyst consensus available
Gynaecological product gets green light, milestone payment coming
Vrylar, jointly developed with US partner AbbVie, is the subject of the positive news
Some fear it could set back the development of treatments for rare diseases
The pharmaceutical manufacturer did not disappoint
EcoMin reveals who can be exempted and how
Márton Nagy says the pharmaceutical sector no longer makes extra profit
Analysts surveyed
Into a single giant company.
Higher TP with 'Overweight' recommendation
Richter will become 100% owner of the two companies for €112 million
Erik Bogsch replaced by E. Szilveszter Vizi
From Erste